03/12/2024
6:45 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
3:20 PM | Pliant Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
7:55 PM | Blue Owl Capital Holdings LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
4:10 PM | First Light Asset Management, LLC (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
7:52 AM | Deep Track Capital, LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
11:29 AM | Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
|
02/05/2024
6:31 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
3:59 PM | BlackRock Inc. (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
01/24/2024
3:56 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:18 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:19 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:19 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:19 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:11 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2023
6:34 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
7:50 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
3:11 PM | Hull Hans (Reporting)
Pliant Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/21/2023
3:40 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
7:23 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
7:26 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
7:29 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
7:31 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
7:20 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
6:26 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
6:17 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
6:19 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
6:22 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
6:14 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
5:14 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:19 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:11 PM | CROWELL GAYLE A (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:14 PM | Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:16 PM | Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:19 PM | Knobil Katharine (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:22 PM | MCCOURT Thomas A (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:24 PM | Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:26 PM | Pliant Therapeutics (Issuer)
Shah Smital (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2023
5:08 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2023
3:01 PM | Pliant Therapeutics (Filer)
| Form DEF 14A | |
